Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel therapy to reduce or eliminate insulin dependence proves effective in NOD mice

April 22, 2002

Lilly claims agonists of PPARalpha and PPARgamma in recent patent

April 19, 2002

Novo Nordisk plans to outlicense NN-622

April 19, 2002

Phytopharm completes installation of P-57 manufacturing plant

April 19, 2002

Discovery Partners and Xenon Genetics collaborate on metabolic syndrome drug discovery

April 18, 2002

Oral PTH analogue for osteoporosis licensed to GlaxoSmithKline

April 17, 2002

BioMarin and Genzyme initiate rolling BLA for Aldurazyme

April 17, 2002

Selective PPARdelta activators and their use

April 16, 2002

Dose-titration study of Symlin initiated in response to FDA approvable letter

April 16, 2002

SSADH deficiency, a potentially treatable neurometabolic disease

April 16, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...